BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 10678914)

  • 1. Salmonella enterica serovar typhimurium surA mutants are attenuated and effective live oral vaccines.
    Sydenham M; Douce G; Bowe F; Ahmed S; Chatfield S; Dougan G
    Infect Immun; 2000 Mar; 68(3):1109-15. PubMed ID: 10678914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Refined live attenuated Salmonella enterica serovar Typhimurium and Enteritidis vaccines mediate homologous and heterologous serogroup protection in mice.
    Tennant SM; Schmidlein P; Simon R; Pasetti MF; Galen JE; Levine MM
    Infect Immun; 2015 Dec; 83(12):4504-12. PubMed ID: 26351285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucosal and systemic immune responses to chimeric fimbriae expressed by Salmonella enterica serovar typhimurium vaccine strains.
    Chen H; Schifferli DM
    Infect Immun; 2000 Jun; 68(6):3129-39. PubMed ID: 10816454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An enterobacterial common antigen mutant of Salmonella enterica serovar Typhimurium as a vaccine candidate.
    Bridge DR; Whitmire JM; Gilbreath JJ; Metcalf ES; Merrell DS
    Int J Med Microbiol; 2015 Sep; 305(6):511-22. PubMed ID: 26070977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mouse models for assessing the cross-protective efficacy of oral non-typhoidal Salmonella vaccine candidates harbouring in-frame deletions of the ATP-dependent protease lon and other genes.
    Matsui H; Fukiya S; Kodama-Akaboshi C; Eguchi M; Yamamoto T
    J Med Microbiol; 2015 Mar; 64(Pt 3):295-302. PubMed ID: 25589672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Salmonella enterica serovar Typhimurium and Choleraesuis slyA mutant strains for use in live attenuated oral vaccines.
    Haneda T; Okada N; Kikuchi Y; Takagi M; Kurotaki T; Miki T; Arai S; Danbara H
    Comp Immunol Microbiol Infect Dis; 2011 Sep; 34(5):399-409. PubMed ID: 21840053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a highly attenuated Salmonella enterica serovar Typhimurium mutant strain.
    Tang IK; Ji DD; Chou CF; Lin HC; Liao CL; Sytwu HK; Wang JJ; Liu YT
    J Microbiol Immunol Infect; 2002 Dec; 35(4):229-35. PubMed ID: 12542248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An attenuated Salmonella enterica serovar Typhimurium strain lacking the ZnuABC transporter induces protection in a mouse intestinal model of Salmonella infection.
    Pesciaroli M; Aloisio F; Ammendola S; Pistoia C; Petrucci P; Tarantino M; Francia M; Battistoni A; Pasquali P
    Vaccine; 2011 Feb; 29(9):1783-90. PubMed ID: 21219981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral immunization with ATP-dependent protease-deficient mutants protects mice against subsequent oral challenge with virulent Salmonella enterica serovar typhimurium.
    Matsui H; Suzuki M; Isshiki Y; Kodama C; Eguchi M; Kikuchi Y; Motokawa K; Takaya A; Tomoyasu T; Yamamoto T
    Infect Immun; 2003 Jan; 71(1):30-9. PubMed ID: 12496146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Igh-6(-/-) (B-cell-deficient) mice fail to mount solid acquired resistance to oral challenge with virulent Salmonella enterica serovar typhimurium and show impaired Th1 T-cell responses to Salmonella antigens.
    Mastroeni P; Simmons C; Fowler R; Hormaeche CE; Dougan G
    Infect Immun; 2000 Jan; 68(1):46-53. PubMed ID: 10603367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterologous Pseudomonas aeruginosa O-antigen delivery using a Salmonella enterica serovar Typhimurium wecA mutant strain.
    Bridge DR; Whitmire JM; Makobongo MO; Merrell DS
    Int J Med Microbiol; 2016 Nov; 306(7):529-540. PubMed ID: 27476047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection against oral challenge three months after i.v. immunization of BALB/c mice with live Aro Salmonella typhimurium and Salmonella enteritidis vaccines is serotype (species)-dependent and only partially determined by the main LPS O antigen.
    Hormaeche CE; Mastroeni P; Harrison JA; Demarco de Hormaeche R; Svenson S; Stocker BA
    Vaccine; 1996 Mar; 14(4):251-9. PubMed ID: 8744548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salmonella flagellin is not a dominant protective antigen in oral immunization with attenuated live vaccine strains.
    Kodama C; Matsui H
    Infect Immun; 2004 Apr; 72(4):2449-51. PubMed ID: 15039380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulated delayed synthesis of lipopolysaccharide and enterobacterial common antigen of Salmonella Typhimurium enhances immunogenicity and cross-protective efficacy against heterologous Salmonella challenge.
    Huang C; Liu Q; Luo Y; Li P; Liu Q; Kong Q
    Vaccine; 2016 Aug; 34(36):4285-92. PubMed ID: 27423383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Salmonella enterica serovar Typhimurium TTSS-2 deficient fur mutant as safe live-attenuated vaccine candidate for immunocompromised mice.
    Vishwakarma V; Pati NB; Chandel HS; Sahoo SS; Saha B; Suar M
    PLoS One; 2012; 7(12):e52043. PubMed ID: 23284865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular and functional characterization of Salmonella enterica serovar typhimurium poxA gene: effect on attenuation of virulence and protection.
    Kaniga K; Compton MS; Curtiss R; Sundaram P
    Infect Immun; 1998 Dec; 66(12):5599-606. PubMed ID: 9826331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic and mucosal immunity induced by attenuated Salmonella enterica serovar Typhimurium expressing ORF7 of porcine reproductive and respiratory syndrome virus.
    Han YW; Kim SB; Rahman M; Uyangaa E; Lee BM; Kim JH; Park KI; Hong JT; Han SB; Eo SK
    Comp Immunol Microbiol Infect Dis; 2011 Jul; 34(4):335-45. PubMed ID: 21543119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of immunogenicity and in vivo distribution of Salmonella enterica serovar Typhi and Typhimurium live vector vaccines delivered by mucosal routes in the murine model.
    Pasetti MF; Pickett TE; Levine MM; Sztein MB
    Vaccine; 2000 Aug; 18(28):3208-13. PubMed ID: 10869765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Salmonella enterica serovar typhimurium succinate dehydrogenase/fumarate reductase double mutant is avirulent and immunogenic in BALB/c mice.
    Mercado-Lubo R; Gauger EJ; Leatham MP; Conway T; Cohen PS
    Infect Immun; 2008 Mar; 76(3):1128-34. PubMed ID: 18086808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective Immunity Elicited by Oral Immunization of Mice with
    Erova TE; Kirtley ML; Fitts EC; Ponnusamy D; Baze WB; Andersson JA; Cong Y; Tiner BL; Sha J; Chopra AK
    Front Cell Infect Microbiol; 2016; 6():148. PubMed ID: 27891321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.